Form 4 for CRBP Corbus Pharmaceuticals Holdings, Inc.
Accepted 2025-06-02 00:00:00 ET · period of report 2025-05-30 · accession 0000950170-25-080311 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-06-02 | 2025-05-30 | CRBP | Jenkins John Kenneth | Dir | A - Grant | $0.00 | +4,800 | 4,833 | +14,545% | $0 |
| DT | 2025-06-02 | 2025-05-30 | CRBP | Jenkins John Kenneth | Dir | S - Sale | $7.35 | -2,783 | 33 | -99% | -$20.5K |
| DT | 2025-06-02 | 2025-05-30 | CRBP | Jenkins John Kenneth | Dir | A - Grant | $0.00 | +16.0K | 16.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2025-05-30 | A | A | 4,800 | $0.00 | 4,833 | D | — | — | (F3) On May 30, 2025, 4,800 restricted stock units ("RSUs") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant. (F4) This amount includes 4,800 unvested RSUs that were granted on May 30, 2025. |
| 2 | Common | Common Stock, par value $0.0001 per share | 2025-05-30 | S | D | 2,783 | $7.35 | 33 | D | — | — | (F2) The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.21 to $7.53. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Stock options (right to buy) | 2025-05-30 | A | A | 16,000 | $0.00 | 16,000 | D | $7.42 · — to 2035-05-30 | 16,000 Common Stock | (F5) The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant. |